See more : Fujian Dongbai (Group) Co.,Ltd. (600693.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Auro Laboratories Limited (AUROLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Auro Laboratories Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Red Sea International Company (4230.SR) Income Statement Analysis – Financial Results
- Medistim ASA (0OCD.L) Income Statement Analysis – Financial Results
- Visual China Group Co.,Ltd. (000681.SZ) Income Statement Analysis – Financial Results
- Poxel S.A. (PXXLF) Income Statement Analysis – Financial Results
- San Lorenzo Gold Corp. (SNLGF) Income Statement Analysis – Financial Results
Auro Laboratories Limited (AUROLAB.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Auro Laboratories Limited
Auro Laboratories Ltd. engages in the business of dealing active pharmaceutical ingredients. The firm also offers bulk drugs. The company was founded on May 26, 1989 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 527.00M | 522.61M | 504.38M | 529.32M | 429.02M | 455.64M | 400.92M | 343.52M | 276.88M | 322.46M | 333.36M | 435.89M | 263.98M | 216.44M | 120.80M | 105.04M | 61.17M |
| Cost of Revenue | 277.61M | 367.26M | 335.79M | 298.35M | 255.69M | 295.61M | 255.65M | 232.12M | 188.22M | 234.85M | 252.69M | 352.41M | 191.66M | 155.52M | 96.54M | 72.39M | 35.74M |
| Gross Profit | 249.39M | 155.35M | 168.59M | 230.97M | 173.34M | 160.03M | 145.27M | 111.40M | 88.66M | 87.62M | 80.67M | 83.47M | 72.32M | 60.92M | 24.26M | 32.65M | 25.42M |
| Gross Profit Ratio | 47.32% | 29.73% | 33.42% | 43.64% | 40.40% | 35.12% | 36.23% | 32.43% | 32.02% | 27.17% | 24.20% | 19.15% | 27.39% | 28.14% | 20.08% | 31.09% | 41.56% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.78M | 3.87M | 3.50M | 3.17M | 4.26M | 3.53M | 4.64M | 3.85M | 2.31M | 1.74M | 1.73M | 1.78M | 0.00 | 3.85M | 5.00M | 0.00 | 0.00 |
| Selling & Marketing | 5.99M | 8.02M | 6.38M | 10.02M | 7.93M | 8.45M | 6.70M | 5.63M | 6.50M | 5.62M | 5.19M | 6.72M | 0.00 | 4.92M | 2.96M | 0.00 | 0.00 |
| SG&A | 14.77M | 11.88M | 9.88M | 13.19M | 12.20M | 11.99M | 11.34M | 9.48M | 8.81M | 7.37M | 6.93M | 8.50M | 0.00 | 8.77M | 7.95M | 0.00 | 0.00 |
| Other Expenses | 234.62M | 4.00K | 3.00K | 35.63K | 1.72K | 310.00 | 145.17K | 88.38K | 6.20K | 49.44K | 28.51K | 1.30K | 498.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 249.39M | 122.17M | 132.51M | 128.91M | 120.87M | 100.18M | 91.00M | 75.75M | 67.46M | 65.39M | 56.99M | 57.86M | 57.51M | 48.62M | 19.22M | 29.11M | 23.44M |
| Cost & Expenses | 426.87M | 489.43M | 468.31M | 427.26M | 376.55M | 395.80M | 346.65M | 307.87M | 255.67M | 300.24M | 309.68M | 410.27M | 249.17M | 204.14M | 115.76M | 101.50M | 59.18M |
| Interest Income | 665.00K | 1.05M | 3.51M | 1.80M | 700.66K | 910.32K | 498.64K | 644.71K | 771.66K | 427.29K | 590.42K | 571.56K | 0.00 | 51.97K | 138.31K | 0.00 | 0.00 |
| Interest Expense | 7.36M | 8.14M | 8.26M | 4.58M | 5.78M | 7.22M | 10.89M | 10.73M | 15.55M | 15.50M | 13.25M | 16.05M | 12.69M | 10.25M | 3.34M | 2.70M | 1.52M |
| Depreciation & Amortization | 10.92M | 10.74M | 10.17M | 10.36M | 10.23M | 10.09M | 9.31M | 8.64M | 6.83M | 7.16M | 7.37M | 7.15M | 4.71M | 4.44M | 3.40M | 2.59M | 2.46M |
| EBITDA | 121.74M | 43.93M | 57.18M | 119.99M | 72.43M | 68.42M | 67.47M | 48.60M | 31.20M | 30.69M | 26.41M | 30.86M | 20.02M | 16.75M | 7.53M | 6.13M | 4.45M |
| EBITDA Ratio | 23.10% | 10.21% | 11.25% | 22.67% | 16.77% | 17.12% | 16.83% | 14.15% | 11.27% | 9.52% | 7.92% | 7.08% | 7.58% | 7.74% | 6.23% | 5.84% | 7.27% |
| Operating Income | 95.78M | 42.60M | 46.55M | 109.64M | 61.73M | 67.91M | 58.16M | 29.14M | 8.81M | 7.99M | 5.76M | 7.66M | 2.61M | 2.05M | 812.66K | 843.00K | 459.00K |
| Operating Income Ratio | 18.17% | 8.15% | 9.23% | 20.71% | 14.39% | 14.90% | 14.51% | 8.48% | 3.18% | 2.48% | 1.73% | 1.76% | 0.99% | 0.95% | 0.67% | 0.80% | 0.75% |
| Total Other Income/Expenses | 7.68M | 1.27M | 2.66M | 2.99M | 3.95M | -7.22M | -7.00M | 88.38K | -11.36M | -13.08M | -17.89M | -17.96M | 8.00K | 0.00 | 2.00 | 0.00 | 0.00 |
| Income Before Tax | 103.46M | 34.46M | 38.74M | 105.05M | 56.42M | 60.69M | 47.27M | 29.23M | 8.82M | 8.04M | 5.79M | 7.67M | 2.62M | 2.05M | 812.66K | 843.00K | 459.00K |
| Income Before Tax Ratio | 19.63% | 6.59% | 7.68% | 19.85% | 13.15% | 13.32% | 11.79% | 8.51% | 3.19% | 2.49% | 1.74% | 1.76% | 0.99% | 0.95% | 0.67% | 0.80% | 0.75% |
| Income Tax Expense | 25.54M | 10.04M | 10.29M | 33.26M | 15.87M | 16.69M | 11.98M | 21.08M | 15.56M | 15.55M | 13.28M | 16.05M | 12.70M | 10.25M | 3.31M | 55.00K | 45.00K |
| Net Income | 77.92M | 24.42M | 28.45M | 71.80M | 40.54M | 43.99M | 35.30M | 8.15M | 8.82M | 8.04M | 5.79M | 7.67M | 2.62M | 2.05M | 812.66K | 788.00K | 414.00K |
| Net Income Ratio | 14.79% | 4.67% | 5.64% | 13.56% | 9.45% | 9.66% | 8.80% | 2.37% | 3.19% | 2.49% | 1.74% | 1.76% | 0.99% | 0.95% | 0.67% | 0.75% | 0.68% |
| EPS | 12.50 | 3.92 | 4.56 | 11.52 | 6.51 | 7.06 | 5.66 | 1.31 | 1.41 | 1.29 | 0.93 | 1.23 | 0.42 | 0.33 | 0.13 | 0.14 | 0.07 |
| EPS Diluted | 12.51 | 3.92 | 4.56 | 11.52 | 6.51 | 7.06 | 5.66 | 1.31 | 1.41 | 1.29 | 0.93 | 1.23 | 0.42 | 0.33 | 0.13 | 0.14 | 0.07 |
| Weighted Avg Shares Out | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.22M | 6.23M | 5.63M | 5.91M |
| Weighted Avg Shares Out (Dil) | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.23M | 6.22M | 6.23M | 5.63M | 5.91M |
No news found for: AUROLAB.BO
Source: https://incomestatements.info
Category: Stock Reports